Gadodiamide

Catalog No.S5000 Synonyms: Omniscan, GDD

For research use only.

Gadodiamide (GDD, Omniscan) is a widely used magnetic resonance imaging (MRI) contrast agent with a high renal toxicity.

Gadodiamide Chemical Structure

CAS No. 131410-48-5

Purity & Quality Control

Related Other Products

Biological Activity

Description Gadodiamide (GDD, Omniscan) is a widely used magnetic resonance imaging (MRI) contrast agent with a high renal toxicity.

Protocol (from reference)

Solubility (25°C)

In vitro

Water 100 mg/mL
(174.31 mM)
DMSO Insoluble
Ethanol Insoluble

Chemical Information

Molecular Weight 573.66
Formula

C16H26GdN5O8

CAS No. 131410-48-5
Storage 3 years -20°C powder
2 years -80°C in solvent

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment Interventions Conditions Sponsor/Collaborators Start Date Phases
NCT04511767 Recruiting Other: Do not take any interventions Autism Spectrum Disorder|Global Developmental Delay|Language Disorder Children''s Hospital of Fudan University September 1 2019 --
NCT00908310 Completed Drug: Omniscan Chronic Kidney Disease|Renal Insufficiency GE Healthcare|i3 Statprobe May 2009 Phase 4
NCT00364585 Completed Device: GreenLight Model 120 Laser System Benign Prostatic Hyperplasia Weill Medical College of Cornell University May 2006 Phase 4

(data from https://clinicaltrials.gov, updated on 2022-01-17)

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Gadodiamide | Gadodiamide ic50 | Gadodiamide price | Gadodiamide cost | Gadodiamide solubility dmso | Gadodiamide purchase | Gadodiamide manufacturer | Gadodiamide research buy | Gadodiamide order | Gadodiamide mouse | Gadodiamide chemical structure | Gadodiamide mw | Gadodiamide molecular weight | Gadodiamide datasheet | Gadodiamide supplier | Gadodiamide in vitro | Gadodiamide cell line | Gadodiamide concentration | Gadodiamide nmr